Register | Log in | FAQ      [?] 

Tag pparg [27 articles]

Recent papers classified by the tag pparg.
  • A Nuclear Receptor Atlas: 3T3-L1 Adipogenesis
    Mol Endocrinol, Vol. 19, No. 10. (1 October 2005), pp. 2437-2450.
    by Mingui Fu, Tingwan Sun, Angie L Bookout, Michael Downes, Ruth T Yu, Ronald M Evans, David J Mangelsdorf
    posted to adipogenesis pparg rxr transcription-factor by vega on 2008-05-24 07:38:04 as **
  • PPARdelta regulates glucose metabolism and insulin sensitivity.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 9. (28 February 2006), pp. 3444-3449.
    by CH Lee, P Olson, A Hevener, I Mehl, LW Chong, JM Olefsky, FJ Gonzalez, J Ham, H Kang, JM Peters, RM Evans
    posted to diabetes pparg review by nprcrzy on 2008-07-18 06:04:57 as **
  • Diabetes, TZDs, and Bone: A Review of the Clinical Evidence.
    PPAR research, Vol. 2006 (2006)
    by AV Schwartz
    posted to diabetes pparg review by nprcrzy on 2008-07-18 05:58:57 as **
  • Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
    J Int Med Res, Vol. 35, No. 4. (g 2007), pp. 482-489.
    posted to rage pparg mesangial mcp1 arb age by jyuh on 2007-10-23 10:08:26 as **
  • Organization and integration of biomedical knowledge with concept maps for key peroxisomal pathways
    Bioinformatics, Vol. 24, No. 16. (15 August 2008), pp. i21-27.
    by AM Willemsen, GA Jansen, JC Komen, S van Hooff, HR Waterham, PMT Brites, RJA Wanders, AHC van Kampen
    posted to pparg knowledgebase by jyuh on 2008-10-14 05:49:00 as ** along with 1 person ptrobajo
  • Ciglitazone, a PPARgamma agonist ameliorates diabetic nephropathy, in part, through homocysteine clearance.
    American journal of physiology. Endocrinology and metabolism (9 September 2008)
    by Utpal Sen, Walter E E Rodriguez, Neetu Tyagi, Munish Kumar, Soumi Kundu, Suresh C C Tyagi
    posted to pparg hcy dn by jyuh on 2008-10-08 15:42:50 as **
  • Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals.
    Arthritis and rheumatism, Vol. 48, No. 1. (January 2003), pp. 231-239.
    posted to pparg pbmc msu by jyuh on 2008-08-17 06:12:02 as **
  • Rosiglitazone Treatment Reduces Diabetic Neuropathy in STZ Treated DBA/2J Mice.
    Endocrinology (26 June 2008)
    by Timothy D D Wiggin, Matthias Kretzler, Subramaniam Pennathur, Kelli A A Sullivan, Frank C C Brosius, Eva L L Feldman
    posted to stz pparg mouse dn by jyuh on 2008-09-07 10:46:09 as **
  • Klotho is a target gene of PPAR-[gamma]
    Kidney Int, Vol. 74, No. 6. (11 June 2008), pp. 732-739.
    by Hong Zhang, Yuanyuan Li, Yanbo Fan, Jing Wu, Beilei Zhao, Youfei Guan, Shu Chien, Nanping Wang
    posted to hek293 klotho pparg by jyuh on 2008-09-01 03:44:52 as **
  • Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    British journal of pharmacology, Vol. 153, No. 7. (April 2008), pp. 1409-1419.
    by GH Hao, XL Niu, DF Gao, J Wei, NP Wang
    posted to pparg pai1 fibroblast ecm aii by jyuh on 2008-09-16 17:21:56 as **
  • Rosiglitazone Prevents Advanced Glycation End ProductsInduced Renal Toxicity Likely through Suppression of Plasminogen Activator Inhibitor-1
    Toxicological Sciences, Vol. 96, No. 2. (April 2007), pp. 346-356.
    posted to rat pparg pai1 mesangial age by jyuh on 2008-01-16 02:12:38 as **
  • PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR- AGONISTS ATTENUATE ANGIOTENSIN II-INDUCED COLLAGEN TYPE I EXPRESSION IN ADVENTITIAL FIBROBLASTS
    Clinical and Experimental Pharmacology and Physiology, Vol. 35, No. 1. (January 2008), pp. 72-77.
    posted to pparg fibroblast collagen aii by jyuh on 2008-09-04 06:10:27 as **
  • Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (24 July 2008)
    by William J J Valentine, Daniel Tucker, Andrew J J Palmer, Michael E E Minshall, Volker Foos, Cheryl Silberman
    posted to pparg meta-analysis dm cea by jyuh on 2008-10-07 08:29:42 as **
  • PPAR-gamma and aging: one link through klotho?
    Kidney international, Vol. 74, No. 6. (September 2008), pp. 702-704.
    by R Zhang, F Zheng
    posted to pparg klotho aging by jyuh on 2008-09-15 05:52:23 as **
  • Fat and Beyond: The Diverse Biology of PPARgamma.
    Annual review of biochemistry, Vol. 77 (7 July 2008), pp. 289-312.
    by Peter Tontonoz, Bruce M M Spiegelman
    posted to pparg by jyuh on 2008-06-16 05:52:30 as ** along with 1 person YamaPing
  • Inhibition of Advanced Glycation End Products. An Implicit Goal in Clinical Medicine for the Treatment of Diabetic Nephropathy?
    Annals of the New York Academy of Sciences, Vol. 1126, No. 1. (2008), pp. 141-146.
    by Toshio Miyata, Yuko Izuhara
    posted to pparg inhibitor dn arb age by jyuh on 2008-04-24 09:39:38 as **
  • Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Toxicol Sci, Vol. 96, No. 2. (April 2007), pp. 346-356.
    by X Yu, C Li, X Li, L Cai
    posted to rat pparg pai1 mesangial age by jyuh on 2008-01-14 12:00:37 as **
  • Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Transplantation, Vol. 84, No. 2. (27 July 2007), pp. 207-213.
    posted to pparg hgf arf by jyuh on 2008-09-06 10:38:53 as **
  • Recent advances in crystal-induced acute inflammation.
    Current opinion in rheumatology, Vol. 19, No. 2. (March 2007), pp. 146-150.
    posted to gout pparg by jyuh on 2008-08-16 11:54:21 as **
  • Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products.
    The Journal of international medical research, Vol. 36, No. 2. (r 2008), pp. 329-335.
    by J Li, NF Liu, Q Wei
    posted to pparg no fibroblast ctgf age by jyuh on 2008-09-16 17:11:47 as **
  • Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
    J Am Soc Nephrol, Vol. 17, No. 6. (June 2006), pp. 1633-1643.
    by SC Tang, JC Leung, LY Chan, AW Tsang, KN Lai
    posted to pt pparg dn by jyuh on 2007-09-19 08:45:42 as **
  • The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells.
    Am J Physiol Renal Physiol, Vol. 287, No. 3. (September 2004)
    posted to pt pparg hk2 hg by jyuh on 2007-09-17 10:25:19 as **
  • Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
    Biochemical and biophysical research communications, Vol. 372, No. 4. (8 August 2008), pp. 713-718.
    by SS Chung, JH Kim, HS Park, HH Choi, KW Lee, YM Cho, HK Lee, KS Park
    posted to sp1 pparg glcnac by jyuh on 2008-09-27 05:45:38 as **
  • Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (3 April 2008)
    by Gang Jee J Ko, Young Sun S Kang, Sang Youb Y Han, Mi Hwa H Lee, Hye Kyoung K Song, Kum Hyun H Han, Hyoung Kyu K Kim, Jee Young Y Han, Dae Ryong R Cha
    posted to rat pparg inflammation dn by jyuh on 2008-04-20 02:12:32 as **
  • Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy.
    American journal of physiology. Renal physiology (30 July 2008)
    by Hongyu Zhang, Jharna Saha, Jaeman Byun, Marylee Schin, Matthew Lorenz, Robert T T Kennedy, Matthias Kretzler, Eva L L Feldman, Subramaniam Pennathur, Frank C C Brosius Iii
    posted to stz ros pparg mouse dn by jyuh on 2008-08-08 14:15:50 as **
  • Peroxisome Proliferator-activated Receptor gamma Ligands Inhibit Estrogen Biosynthesis in Human Breast Adipose Tissue: Possible Implications for Breast Cancer Therapy
    Cancer Res, Vol. 60, No. 6. (1 March 2000), pp. 1604-1608.
    by Gary L Rubin, Ying Zhao, Allan M Kalus, Evan R Simpson
    posted to adipose aromatase estradiol estrogens glitazones human pparg by FW_Gibb on 2007-05-27 10:11:20 as **
  • Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans.
    PLoS Med, Vol. 4, No. 3. (6 March 2007)
    by Anthony E E Civitarese, Stacy Carling, Leonie K K Heilbronn, Mathew H H Hulver, Barbara Ukropcova, Walter A A Deutsch, Steven R R Smith, Eric Ravussin
  • Note: You may cite this page as: http://www.citeulike.org/tag/pparg

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.